The preliminary reports about SARS-CoV-2 presented high spread potential but no evidence for high mortality or virulence, suggesting that these new mutations may be suitable for the consideration of vaccine development research.
Dear Murad!
Of course, they are suitable, moreover, the mutant proteins of the virus are used as targets for the targeted action of vaccines or drugs. For example, a D614G mutation in S spike protein of COVID-19.
https://www.nature.com/articles/s41392-020-00352-y
https://www.pnas.org/content/117/38/23652
Sequence Identity with Potential Vaccine Candidates.
Article Implications of SARS-CoV-2 genetic diversity and mutations o...
Pfizer COVID-19 vaccine seems effective against mutant variants of SARS-CoV-2.
Preprint Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccin...
A new coronavirus mutation has just been been discovered among 35 newly infected patients in Garmisch-Partenkirchen, Bavaria (Germany). It is said to be different to the one originally discovered in the UK, but doctors do not yet know if it is as highly infectious as the UK or South Africa variants.
https://www.dw.com/en/germany-new-covid-variant-found-in-bavaria/a-56269615
Apparently all currently approved vaccines are also effective against the newly discovered variants found e.g. in the UK and South Africa.
Currently in our country, Germany, there is a growing concern about the dangerous and more contagious South African coronavorus variant. Please see this recent link entitled
"Coronavirus: Africa's new variants are causing growing concern"
https://www.bbc.com/news/world-africa-53181555
Dear Murad Alahdal currently the coronavirus is spreading even faster due to the appearance of the new mutations (UK, South Africa, Brazil). Please see this useful recent link entitled
"What’s the risk of dying from a fast-spreading COVID-19 variant?"
https://www.nature.com/articles/d41586-021-00299-2